Find a Specialist by Postal Code | Page 7 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Lawrence Rice, MD Houston Methodist Hospital Houston Texas United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Leslie Ellis, BS, MD Wake Forest Baptist Health Comprehensive Cancer Center Winston-Salem North Carolina United States
  • Acute Myeloid Leukemia (AML)
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Lionel Ades, MD, PhD Hôpital Saint-Louis Paris France
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Luca Malcovati, MD IRCCS S. Matteo Hospital Foundation & University of Pavia Pavia Pavia Italy
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Lucy Godley, MD, PhD University of Chicago Duchossois Center for Advanced Medicine - Hyde Park Chicago Illinois United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Mahasweta Gooptu, MD Dana-Farber cancer Institute Boston Massachusetts United States
Marcin Wlodarski, MD, PhD St Jude Children’s Research Hospital Memphis Tennessee United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Maria Baer, MD University of Maryland Greenebaum Comprehensive Cancer Center Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Marie Sebert, MD, PhD Hôpital Saint-Louis Paris Paris (75) France
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Mark Goodman, MD University of Miami Health System - Sylvester Comprehensive Cancer Center Miami Florida United States
  • Aplastic Anemia
Mark Levis, MD, PhD Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
Mark Litzow, MD Mayo Clinic - Rochester Rochester Minnesota United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Marlise Luskin, MD, MSCE Dana Farber Cancer Institute Boston Massachusetts United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Mary Armanios, MD Johns Hopkins University Baltimore Maryland United States
Matthew Fero, MD, FACP University of New Mexico Comprehensive Cancer Center Albuquerque New Mexico United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
Matthew Walter, MD Washington University - Barnes Jewish Hospital St. Louis Missouri United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Maxim Norkin, MD, PhD Baptist MD Anderson Cancer Center Jacksonville Florida United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Mehmet Compur, MD, FACP Marylanning Health Care Hastings Nebraska United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Melhem Solh, MD Northside Hospital Cancer Institute Atlanta Georgia United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Michael Burke, MD Children's Wisconsin-Milwaukee Hospital Milwaukee Wisconsin United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Pediatric